Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gain Therapeutics (GANX) Pension (2020 - 2025)

Gain Therapeutics has reported Pension over the past 6 years, most recently at $527825.0 for Q3 2025.

  • Quarterly results put Pension at $527825.0 for Q3 2025, up 63.28% from a year ago — trailing twelve months through Sep 2025 was $527825.0 (up 63.28% YoY), and the annual figure for FY2024 was $443623.0, up 44.29%.
  • Pension for Q3 2025 was $527825.0 at Gain Therapeutics, up from $522676.0 in the prior quarter.
  • Over the last five years, Pension for GANX hit a ceiling of $527825.0 in Q3 2025 and a floor of $157580.0 in Q4 2022.
  • Median Pension over the past 5 years was $307454.0 (2023), compared with a mean of $314115.5.
  • Biggest five-year swings in Pension: plummeted 57.51% in 2023 and later surged 101.4% in 2024.
  • Gain Therapeutics' Pension stood at $329458.0 in 2021, then crashed by 52.17% to $157580.0 in 2022, then skyrocketed by 95.11% to $307454.0 in 2023, then surged by 44.29% to $443623.0 in 2024, then increased by 18.98% to $527825.0 in 2025.
  • The last three reported values for Pension were $527825.0 (Q3 2025), $522676.0 (Q2 2025), and $470856.0 (Q1 2025) per Business Quant data.